Medidata and Project ALS partner to develop new therapeutic strategies
Medidata, a subsidiary of Dassault Systèmes, and Project ALS have entered a research partnership in order to develop new therapeutic…
Latest Diagnostics
-
8 months
-
1 year
-
2 years
-
8 months
-
1 year
-
2 years
August’s top news stories
Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of…
Latest News
View More
Medidata and Project ALS partner to develop new therapeutic strategies
Medidata, a subsidiary of Dassault Systèmes, and Project ALS have entered a research partnership in order to develop new therapeutic strategies for the treatment of…
Study assesses blood test to match patients to clinical trials
Researchers from the University of Manchester’s CRUK Manchester Institute are conducting a clinical study, dubbed TARGET, to evaluate the use of a blood test in…
Latest Content
View MoreWAKIX (pitolisant) for the Treatment of Cataplexy with Narcolepsy
WAKIX® (pitolisant) is the first and only non-scheduled medication indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS)…
Real Time Cargo Intelligence to Increase Distribution Quality and Security
Smooth visibility from the place of production to the ultimate destination must be the new standard for vaccine delivery. The…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…